Fujian Medical University Union Hospital

This study is for adults newly diagnosed with a type of acute myeloid leukemia (non-M3). It tests whether adding silibinin, a natural compound from milk thistle that protects the liver, to standard chemotherapy can improve remission rates and survival. About 100 participants will…

This study tests a treatment plan tailored to each patient's PD-L1 level (CPS score) before surgery for locally advanced esophageal cancer. About 90 adults will receive this personalized neoadjuvant therapy to see if it can eliminate all cancer cells before the operation. The goa…

This study tests whether a combination of two targeted drugs (zanidatamab and tislelizumab) plus chemotherapy can shrink HER2-positive muscle-invasive bladder cancer enough to avoid bladder removal. About 25 adults with stage T2-T4a bladder cancer will receive the treatment befor…

This study tests a personalized vaccine made from a patient's own leukemia cells to help prevent the cancer from coming back. It is for adults with acute myeloid leukemia who are in remission after chemotherapy. The vaccine is designed to train the immune system to recognize and …

This study tests whether tiny particles from stem cells (exosomes) can safely help regrow hair in men with androgenic alopecia (male pattern baldness). The exosomes are delivered into the scalp using a microneedle device. The trial will enroll 18 men aged 18 to 60 with mild to mo…

This study compares a personalized biopsy method that uses fewer needle cores to the standard approach for diagnosing prostate cancer. Researchers will enroll 330 men with suspected prostate cancer and randomly assign them to either the personalized or standard biopsy. The goal i…

This study tests whether a non-invasive treatment called repetitive transcranial magnetic stimulation (rTMS) can improve thinking and daily function in people with mild to moderate Alzheimer's disease. Researchers will use brain scans and electrical recordings to understand how r…

This study looks at how substances in the bone marrow, like IL-6 and leptin, influence chemotherapy resistance in acute myeloid leukemia (AML). Researchers will enroll 405 newly diagnosed AML patients and 81 healthy controls to measure these factors and link them to treatment out…

This study looks at whether levels of a protein called leptin in bone marrow fluid can predict how well chemotherapy works in adults with acute myeloid leukemia (AML). Researchers will measure leptin before treatment and compare it to how patients respond. The goal is to find a w…